UNC 0224

Pricing Availability   Qty
说明: Potent G9a and GLP inhibitor
化学名: 7-[3-(Dimethylamino)propoxy]-2-(hexahydro-4-methyl-1H-1,4-diazepin-1-yl)-6-methoxy-N-(1-methyl-4-piperidinyl)-4-quinazolinamine
纯度: ≥98% (HPLC)
说明书
引用文献
评论
文献 (2)

生物活性 for UNC 0224

UNC 0224 is a potent G9a and GLP inhibitor (IC50 values are 15 and 20 nM in a ThioGlo assay, respectively). Exhibits >1000-fold selectivity for G9a over SET7, SET8 and SET9. UNC 0224 can be used in protocols for the chemical reprogramming of somatic cells to iPSCs.

技术数据 for UNC 0224

分子量 485.67
公式 C26H43N7O2
储存 Store at +4°C
纯度 ≥98% (HPLC)
CAS Number 1197196-48-7
PubChem ID 44251522
InChI Key XIVUGRBSBIXXJE-UHFFFAOYSA-N
Smiles CN(CC4)CCC4NC1=C2C(C=C(OCCCN(C)C)C(OC)=C2)=NC(N3CCCN(C)CC3)=N1

上方提供的技术数据仅供参考。批次相关数据请参见分析证书。

Tocris products are intended for laboratory research use only, unless stated otherwise.

溶解性数据 for UNC 0224

溶剂 最高浓度 mg/mL 最高浓度 mM
溶解性
1eq. HCl 48.57 100
DMSO 48.57 100

制备储备液 for UNC 0224

以下数据基于产品分子量 485.67。 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

选择批次从而根据批次分子量重新计算:
浓度/溶剂体积/质量 1 mg 5 mg 10 mg
1 mM 2.06 mL 10.3 mL 20.59 mL
5 mM 0.41 mL 2.06 mL 4.12 mL
10 mM 0.21 mL 1.03 mL 2.06 mL
50 mM 0.04 mL 0.21 mL 0.41 mL

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

产品说明书 for UNC 0224

分析证书/产品说明书
选择另一批次:

参考文献 for UNC 0224

参考文献是支持产品生物活性的出版物。

Liu et al (2009) Discovery of a 2,4-diamino-7-aminoalkoxyquinazoline as a potent and selective inhibitor of histone lysine methyltransferase G9a. J.Med.Chem. 52 7950 PMID: 19891491

Guan et al (2022) Chemical reprogramming of human somatic cells to pluripotent stem cells. Nature 605 325 PMID: 35418683


If you know of a relevant reference for UNC 0224, please let us know.

按产品操作查看相关产品

查看全部 G9a/GLP Inhibitors

关键词: UNC 0224, UNC 0224 supplier, UNC0224, potent, inhibitors, inhibits, histone, lysine, methyltransferases, htmase, G9a, epigenetics, GLP, induced, pluripotent, stem, cells, reprogramming, iPSC, Lysine, Methyltransferases, G9a/GLP, Stem, Cell, Reprogramming, 3861, Tocris Bioscience

篇 UNC 0224 的引用文献

引用文献是使用了 Tocris 产品的出版物。

目前没有 UNC 0224 的引用文献。 您是否知道使用了 Tocris UNC 0224 的优秀论文? 请告知我们.

UNC 0224 的评论

目前没有该产品的评论。 Be the first to review UNC 0224 and earn rewards!

Have you used UNC 0224?

Submit a review and receive an Amazon gift card.

$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image

$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review

该领域的文献

Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* your copy today!

*请注意,Tocris 仅会向正规科研企业/机构地址发送文献。


Epigenetics Scientific Review

Epigenetics Scientific Review

Written by Susanne Müller-Knapp and Peter J. Brown, this review gives an overview of the development of chemical probes for epigenetic targets, as well as the impact of these tool compounds being made available to the scientific community. In addition, their biological effects are also discussed. Epigenetic compounds available from Tocris are listed.

Epigenetics in Cancer Poster

Epigenetics in Cancer Poster

This poster summarizes the main epigenetic targets in cancer. The dysregulation of epigenetic modifications has been shown to result in oncogenesis and cancer progression. Unlike genetic mutations, epigenetic alterations are considered to be reversible and thus make promising therapeutic targets.